ABBOTT LABSABBOTT LABSABBOTT LABS

ABBOTT LABS

No trades
See on Supercharts
Market capitalization
‪177.96 B‬EUR
‪5.17 B‬EUR
‪36.34 B‬EUR
‪1.72 B‬
Beta (1Y)
0.57

About ABBOTT LABS

CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Employees (FY)
‪114 K‬
Founded
1888
ISIN
US0028241000
FIGI
BBG000H2SMX1
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ABL is 102.08 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HAN exchange ABBOTT LABS stocks are traded under the ticker ABL.
ABBOTT LABS is going to release the next earnings report on Apr 17, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ABBOTT LABS has a max estimate of 129.88 EUR and a min estimate of 98.56 EUR.
ABL earnings for the last quarter are 1.08 EUR whereas the estimation was 1.04 EUR which accounts for 3.57% surprise. Estimated earnings for the next quarter are 1.08 EUR. See more details about ABBOTT LABS earnings.
ABBOTT LABS revenue for the last quarter amounts to ‪9.60 B‬ EUR despite the estimated figure of ‪9.31 B‬ EUR. In the next quarter revenue is expected to reach ‪9.23 B‬ EUR.
Yes, you can track ABBOTT LABS financials in yearly and quarterly reports right on TradingView.
Like other stocks, ABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABS stock right from TradingView charts — choose your broker and connect to your account.
ABL reached its all-time high on Jan 3, 2022 with the price of 124.90 EUR, and its all-time low was 45.94 EUR and was reached on Feb 9, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪114.00 K‬ employees. See our rating of the largest employees — is ABBOTT LABS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABS EBITDA is ‪8.78 B‬ EUR, and current EBITDA margin is 24.13%. See more stats in ABBOTT LABS financial statements.